Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-1017 Copy Product Info
🥰Excellent
Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human anti-CCL2 (chemokine ligand 2) antibody Carlumab, connected via the Mc-VC-PAB linker to the topoisomerase I inhibitor SN38. The toxic component and linker of the ADC is Mc-VC-PAB-SN38. This ADC is employed in cancer research studies.

Anti-CCL2
(Carlumab)-MC-Vc-PAB-SN38

Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human anti-CCL2 (chemokine ligand 2) antibody Carlumab, connected via the Mc-VC-PAB linker to the topoisomerase I inhibitor SN38. The toxic component and linker of the ADC is Mc-VC-PAB-SN38. This ADC is employed in cancer research studies.
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Antigen Details
TargetCCL2
Storage & Solubility Information
StorageStore at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: